Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Conditions
IC-MPGN
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Lama Abdelnour)Univ Cali Irvine ALS Neuromuscular, Orange, California, United States
Contact: Principal Investigator (Ramy Hanna)UCSF, San Francisco, California, United States
Contact: Principal Investigator (Raymond Hsu)Olive View UCLA Medical Center, Sylmar, California, United States
Contact: Principal Investigator (Phuong-Chi Pham)Childrens Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Bradley Dixon)Nicklaus Childrens Hospital, Miami, Florida, United States
Contact: Principal Investigator (Ana Paredes.)Emory University School of Medicine-Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Laurence Larry Greenbaum)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Meghan Sise)Boston Univ School of Medicine, Boston, Massachusetts, United States
Contact: Principal Investigator (Jean Francis)University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Nattawat Klomjit)Washington University in St Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Tingting Li)University of New Mexico, Albuquerque, New Mexico, United States
Contact: Principal Investigator (Namita Singh)Col Uni Med Center New York Presby, New York, New York, United States
Contact: Principal Investigator (Andrew S Bomback)University Of Cincinnati, Cincinnati, Ohio, United States
Contact: Principal Investigator (Manish Anand)OHSU Dept of Nephrology, Portland, Oregon, United States
Contact: Principal Investigator (Rupali Avasare)Univ of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Gaia Coppock)MUSC Health Lancaster Med Ctr, Lancaster, South Carolina, United States
Contact: Principal Investigator (Prince Anand)UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Jyothsna Gattineni)Prolato Clinical Research Center, Houston, Texas, United States
Contact: Principal Investigator (Sreedhar Mandayam.)Baylor Scott and White Research, Temple, Texas, United States
Contact: Principal Investigator (Mohanram Narayanan)University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Raoul Nelson)University of Wisconsin, Madison, Wisconsin, United States
Contact: Principal Investigator (Sharon Bartosh)Novartis Investigative Site, CABA, Buenos Aires, Argentina
Novartis Investigative Site, CABA, Buenos Aires, Argentina
Novartis Investigative Site, Córdoba, Córdoba Province, Argentina
Novartis Investigative Site, Buenos Aires, Argentina
Novartis Investigative Site, CABA, Argentina
Novartis Investigative Site, Santa Fe, Argentina
Novartis Investigative Site, Fortaleza, Ceará, Brazil
Novartis Investigative Site, Brasília, Federal District, Brazil
Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil
Novartis Investigative Site, Recife, Pernambuco, Brazil
Novartis Investigative Site, Niterói, Rio de Janeiro, Brazil
Novartis Investigative Site, Rio de Janeiro, Rio de Janeiro, Brazil
Novartis Investigative Site, Natal, Rio Grande do Norte, Brazil
Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil
Novartis Investigative Site, Botucatu, São Paulo, Brazil
Novartis Investigative Site, Santo André, São Paulo, Brazil
Novartis Investigative Site, Sao Jose Rio Preto, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, Salvador, Brazil
Novartis Investigative Site, Etobicoke, Ontario, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Prague, Czechia
Novartis Investigative Site, Aarhus N, Denmark
Novartis Investigative Site, Copenhagen, Denmark
Novartis Investigative Site, Marseille, France
Novartis Investigative Site, Montpellier, France
Novartis Investigative Site, Paris, France
Novartis Investigative Site, Rennes, France
Novartis Investigative Site, Toulouse, France
Novartis Investigative Site, Munich, Bavaria, Germany
Novartis Investigative Site, Würzburg, Bavaria, Germany
Novartis Investigative Site, Dresden, Saxony, Germany
Novartis Investigative Site, Jena, Thuringia, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Hanover, Germany
Novartis Investigative Site, Mainz, Germany
Novartis Investigative Site, Ulm, Germany
Novartis Investigative Site, Athens, Greece
Novartis Investigative Site, Chaïdári, Greece
Novartis Investigative Site, Heraklion Crete., Greece
Novartis Investigative Site, Ioannina, Greece
Novartis Investigative Site, Pátrai, Greece
Novartis Investigative Site, Thessaloniki, Greece
Novartis Investigative Site, Thessaloniki, Greece
Novartis Investigative Site, Bangalore, Karnataka, India
Novartis Investigative Site, Nagpur, Maharashtra, India
Novartis Investigative Site, Pune, Maharashtra, India
Novartis Investigative Site, New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site, Hyderabad, Telangana, India
Novartis Investigative Site, Haifa, Israel
Novartis Investigative Site, Jerusalem, Israel
Novartis Investigative Site, Petah Tikva, Israel
Novartis Investigative Site, Bari, BA, Italy
Novartis Investigative Site, Ranica, BG, Italy
Novartis Investigative Site, Brescia, BS, Italy
Novartis Investigative Site, Milan, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Torino, TO, Italy
Novartis Investigative Site, Naples, Italy
Novartis Investigative Site, Toyoake, Aichi-ken, Japan
Novartis Investigative Site, Fuchū, Tokyo, Japan
Novartis Investigative Site, Hachiōji, Tokyo, Japan
Novartis Investigative Site, Okayama, Japan
Novartis Investigative Site, Osaka, Japan
Novartis Investigative Site, Groningen, Netherlands
Novartis Investigative Site, Poznan, Greater Poland Voivodeship, Poland
Novartis Investigative Site, Bialystok, Poland
Novartis Investigative Site, Krakow, Poland
Novartis Investigative Site, Olsztyn, Poland
Novartis Investigative Site, Warsaw, Poland
Novartis Investigative Site, Warsaw, Poland
Novartis Investigative Site, Wroclaw, Poland
Novartis Investigative Site, Martin, Slovakia, Slovakia
Novartis Investigative Site, Banská Bystrica, Slovakia
Novartis Investigative Site, Košice, Slovakia
Novartis Investigative Site, Seoul, Seoul, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Pamplona, Navarre, Spain
Novartis Investigative Site, Almería, Spain
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Salamanca, Spain
Novartis Investigative Site, Bern, Switzerland
Novartis Investigative Site, Lausanne, Switzerland
Novartis Investigative Site, Zurich, Switzerland
Novartis Investigative Site, Kaohsiung City, Taiwan
Novartis Investigative Site, Istanbul, Fatih, Turkey (Türkiye)
Novartis Investigative Site, Izmir, Karsiyaka, Turkey (Türkiye)
Novartis Investigative Site, Köseköy, Kocaeli, Turkey (Türkiye)
Novartis Investigative Site, Kayseri, Melikgazi, Turkey (Türkiye)
Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
Novartis Investigative Site, Mersin, Yenisehir, Turkey (Türkiye)
Novartis Investigative Site, Belfast, United Kingdom
Novartis Investigative Site, Cardiff, United Kingdom
Novartis Investigative Site, London, United Kingdom
Novartis Investigative Site, London, United Kingdom
Novartis Investigative Site, Manchester, United Kingdom
Novartis Investigative Site, Salford, United Kingdom
Novartis Investigative Site, Ho Chi Minh City, Vietnam
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals